---
figid: PMC5464836__oncotarget-08-32884-g009
figtitle: Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and
  suppresses metastasis of lung cancer cells
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
organisms_ner:
- Bos taurus
- Mus musculus
- Homo sapiens
- Oryctolagus cuniculus
- Danio rerio
pmcid: PMC5464836
filename: oncotarget-08-32884-g009.jpg
figlink: /pmc/articles/PMC5464836/figure/F9/
number: F9
caption: Lung cancer cells which express low but adequate levels of TLR3 protein engages
  polyI:C, which in turn activates TLR3-mediated caspase 3/8 apoptosis pathway. Single
  treatment with polyI:C alone suppresses survival, oncogenicity and metastatic potential
  of lung cancer cells (e.g. A549, NCI-H292). In addition to apoptosis, polyI:C increases
  the secretion of IL6 through activation of STAT3 and JAK2. A combinatorial treatment
  with polyI:C and anti-IL6 antibody decreases IL6 production and subsequently enhances
  the polyI:C-killing and suppresses oncogenicity and metastatic potential of A549.
  Similarly, blockade of STAT3 and JAK2 activities by Stattic and AG490 antagonists,
  respectively, enhances the cancer killing effect of polyI:C. Taken together, a combinatorial
  treatment of polyI:C+anti-IL6 enhances the impact of polyI:C-killing of A549 through
  IL6/JAK2/STAT3 signalling pathway.
papertitle: Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and
  suppresses metastasis of lung cancer cells.
reftext: Wai Hoe Lau, et al. Oncotarget. 2017 May 16;8(20):32884-32904.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9444005
figid_alias: PMC5464836__F9
figtype: Figure
redirect_from: /figures/PMC5464836__F9
ndex: eae19e13-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5464836__oncotarget-08-32884-g009.html
  '@type': Dataset
  description: Lung cancer cells which express low but adequate levels of TLR3 protein
    engages polyI:C, which in turn activates TLR3-mediated caspase 3/8 apoptosis pathway.
    Single treatment with polyI:C alone suppresses survival, oncogenicity and metastatic
    potential of lung cancer cells (e.g. A549, NCI-H292). In addition to apoptosis,
    polyI:C increases the secretion of IL6 through activation of STAT3 and JAK2. A
    combinatorial treatment with polyI:C and anti-IL6 antibody decreases IL6 production
    and subsequently enhances the polyI:C-killing and suppresses oncogenicity and
    metastatic potential of A549. Similarly, blockade of STAT3 and JAK2 activities
    by Stattic and AG490 antagonists, respectively, enhances the cancer killing effect
    of polyI:C. Taken together, a combinatorial treatment of polyI:C+anti-IL6 enhances
    the impact of polyI:C-killing of A549 through IL6/JAK2/STAT3 signalling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - JAK2
  - STAT3
  - TLR3
  - TICAM1
  - Il6
  - Jak2
  - Stat3
  - Tlr3
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Ralbp1
  - Ripk1
  - Casp3
  - Il11ra1
  - Il6st
  - Lrpprc
  - TRIM69
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IL6ST
  - NM
  - LRPPRC
  - il6
  - jak2b
  - stat3
  - tlr3
  - ticam1
  - ripk1l
  - casp8
  - il6st
---
